Current status of first‐line treatment with pembrolizumab for non–small‐cell lung cancer with high PD‐L1 expression
暂无分享，去创建一个
S. Oizumi | Y. Kitamura | M. Shimokawa | H. Mizugaki | A. Nakamura | M. Kobayashi | T. Hachiya | Y. Ikezawa | Megumi Furuta | M. Aso | Hisashi Tanaka | Keiki Yokoo | Kazunari Tateishi | R. Morita | F. Yoshiike | Toshiyuki Sumi | H. Kikuchi | Nozomu Kimura | M. Sekikawa | Keiichi Nakamura | K. Yokoo | K. Tateishi